Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 1976-1986

  Astapova, Inna ^a   Ramadoss, Preeti ^a   Costa E Sousa, Ricardo H ^a,c   Ye, Felix ^a   Holtz, Kaila A ^a   Li, Yingxia ^b   Niepel, Michele W ^b   Cohen, David E ^b   Hollenberg, Anthony N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE SALT EXPORT PUMP; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; CYTOCHROME P450 3A11; HEPATIC NUCLEAR COREPRESSOR 1; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEAR RECEPTOR COREPRESSOR; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA 1; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HYDROPHOBICITY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTANETRIOL 26-MONOOXYGENASE; CHOLESTEROL; CYTOCHROME P-450 CYP3A; DIETARY FATS; LIVER; MEMBRANE PROTEINS; MICE, KNOCKOUT; NUCLEAR RECEPTOR CO-REPRESSOR 1; ORPHAN NUCLEAR RECEPTORS; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES;

EID: 84899713415     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI73419     Document Type: Article

References (64)

1. Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(8):1513-1518.
2. Erion MD, et al. Targeting thyroid hormone receptor- beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci U S A. 2007;104(39):15490-15495.
3. Berkenstam A, et al. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci U S A. 2008;105(2):663-667.
4. Ladenson PW, et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med. 2010;362(10):906-916.
5. Johansson L, et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci U S A. 2005; 102(29):10297-10302.
6. Tancevski I, et al. The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice. PLoS One. 2010;5(1):e8722.
7. Gullberg H, Rudling M, Forrest D, Angelin B, Vennstrom B. Thyroid hormone receptor betadeficient mice show complete loss of the normal cholesterol 7-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol Endocrinol. 2000;14(11):1739-1749.
8. Drover VA, Agellon LB. Regulation of the human cholesterol 7-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. Endocrinology. 2004;145(2):574-581.
9. Lin JZ, et al. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology. 2012;153(12):6136-6144.
10. Abrams JJ, Grundy SM. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res. 1981;22(2):323-338.
11. Galman C, Bonde Y, Matasconi M, Angelin B, Rudling M. Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone. Gastroenterology. 2008;134(4):1127-1136.
12. Bonde Y, Plosch T, Kuipers F, Angelin B, Rudling M. Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex. Hepatology. 2012;56(5):1828-1837.
13. Gullberg H, Rudling M, Salto C, Forrest D, Angelin B, Vennstrom B. Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol. 2002;16(8):1767-1777.
14. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR?. Nature. 1996;383(6602):728-731.
15. Peet DJ, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR?. Cell. 1998;93(5):693-704.
16. Alberti S, et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXR-deficient mice. J Clin Invest. 2001;107(5):565-573.
17. Zhang Y, et al. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest. 2012;122(5):1688-1699.
18. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXR). Gene. 2001;262(1-2):257-265.
19. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. Regulation of ATPbinding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors and. J Biol Chem. 2002;277(21):18793-18800.
20. Astapova I, Lee LJ, Morales C, Tauber S, Bilban M, Hollenberg AN. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci U S A. 2008;105(49):19544-19549.
21. Astapova I, et al. The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary- thyroid axis. Mol Endocrinol. 2011;25(2):212-224.
22. Day R, et al. Time course of hepatic 3-hydroxy- 3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole- treated hypothyroid and hypophysectomized rats after triiodothyronine administration: possible linkage of cholesterol synthesis to biliary secretion. Endocrinology. 1989;125(1):459-468.
23. Vanpatten S, Karkanias GB, Rossetti L, Cohen DE. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J. 2004; 379(pt 2):229-233.
24. Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 2009;325(5936):100-104.
25. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem. 2003;278(18):15565- 15570.
26. Turley SD, Herndon MW, Dietschy JM. Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J Lipid Res. 1994;35(2):328-339.
27. Wang DQ, Carey MC. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res. 2003;44(5):1042-1059.
28. Wang DQ, Tazuma S, Cohen DE, Carey MC. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstonesusceptible mouse. Am J Physiol Gastrointest Liver Physiol. 2003;285(3):G494-G502.
29. Cohen BI, Raicht RF, Mosbach EH. Sterol metabolism studies in the rat. Effects of primary bile acids (sodium taurochenodeoxycholate and sodium taurocholate) on sterol metabolism. J Lipid Res. 1977;18(2):223-231.
30. Hyogo H, Roy S, Paigen B, Cohen DE. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem. 2002;277(37):34117-34124.
31. Andersson U, Yang YZ, Bjorkhem I, Einarsson C, Eggertsen G, Gafvels M. Thyroid hormone suppresses hepatic sterol 12-hydroxylase (CYP8B1) activity and messenger ribonucleic acid in rat liver: failure to define known thyroid hormone response elements in the gene. Biochim Biophys Acta. 1999;1438(2):167-174.
32. Slatis K, et al. Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice. J Lipid Res. 2010;51(11):3289-3298.
33. Furster C, Wikvall K. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5-cholestane-3,7,12-triol in human liver microsomes. Biochim Biophys Acta. 1999;1437(1):46-52.
34. Honda A, et al. Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011;52(8):1509-1516.
35. Gnerre C, et al. LXR deficiency and cholesterol feeding affect the expression and phenobarbitalmediated induction of cytochromes P450 in mouse liver. J Lipid Res. 2005;46(8):1633-1642.
36. Yuan C, et al. Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1. Endocrinology. 2012;153(1):501-511.
37. Park YJ, Lee EK, Lee YK, Park do J, Jang HC, Moore DD. Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice. Toxicol Appl Pharmacol. 2012;263(2):131-137.
38. Hernandez JP, Mota LC, Huang W, Moore DD, Baldwin WS. Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR). Toxicology. 2009;256(1-2):53-64.
39. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem. 2001;276(31):28857-28865.
40. Kalaany NY, et al. LXRs regulate the balance between fat storage and oxidation. Cell Metab. 2005;1(4):231-244.
41. Ramadoss P, et al. Novel mechanism of positive versus negative regulation by thyroid hormone receptor 1 (TR1) identified by genome-wide profiling of binding sites in mouse liver. J Biol Chem. 2014;289(3):1313-1328.
42. Feng D, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science. 2011;331(6022):1315-1319.
43. Mason RL, Hunt HM, Hurxthal L. Blood cholesterol values in hyperthyroidism and hypothyroidism - their significance. N Engl J Med. 1930;203(26):1273-1277.
44. Chopra AR, et al. Cellular energy depletion resets whole-body energy by promoting coactivatormediated dietary fuel absorption. Cell Metab. 2011;13(1):35-43.
45. Yamamoto H, et al. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell. 2011;147(4):827-839.
46. Li P, et al. Adipocyte NCoR knockout decreases PPAR phosphorylation and enhances PPAR activity and insulin sensitivity. Cell. 2011;147(4):815-826.
47. Wagner BL, et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol. 2003;23(16):5780-5789.
48. Albers M, et al. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J Biol Chem. 2006;281(8):4920-4930.
49. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266(12):7779-7783.
50. Rosen H, et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem. 1998; 273(24):14805-14812.
51. Repa JJ, et al. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem. 2000;275(50):39685-39692.
52. Dubrac S, et al. Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res. 2005;46(1):76-85.
53. Meir K, et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J Biol Chem. 2002;277(37):34036-34041.
54. Inoue S, Yoshinari K, Sugawara M, Yamazoe Y. Activated sterol regulatory element-binding protein-2 suppresses hepatocyte nuclear factor-4-mediated Cyp3a11 expression in mouse liver. Mol Pharmacol. 2011;79(1):148-156.
55. Strautnieks SS, et al. A gene encoding a liverspecific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998;20(3):233-238.
56. Wang R, et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A. 2001;98(4):2011-2016.
57. Figge A, et al. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem. 2004; 279(4):2790-2799.
58. Roy S, et al. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse. Hepatology. 2005; 41(4):887-895.
59. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol. 2001;281(2):G393-G404.
60. Bradley MN, et al. Ligand activation of LXR reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR and apoE. J Clin Invest. 2007;117(8):2337-2346.
61. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497-509.
62. Locket PL, Gallaher DD. An improved procedure for bile acid extraction and purification and tissue distribution in the rat. Lipids. 1989;24(3):221-223.
63. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res. 1989;30(5):719-730.
64. Bhatnagar S, Damron HA, Hillgartner FB. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem. 2009;284(15):10023-10033.